Jardiance® reduced risk of cardiovascular death in adults with type 2 diabetes and peripheral artery disease
INGELHEIM, Germany & INDIANAPOLIS -- (BUSINESS WIRE) -- New data showed that empagliflozin reduced the risk of cardiovascular death compared with placebo when added to standard of care in adult......